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Ethics ofEugineering Education
VACCINE MANUFACTURING IN ISLAMIC PERSPECTIVE
Maizirwan Mel and Ja'afar Nuhu Ja'afar
ABSTRACT
Recent progress in biotechnology and basic immunology is leading to the development of a wide
range of new vaccines raising possibilities for the prevention of infectious diseases. In addition,
improvement to already licensed vaccine is also being considered leading to new products as well
as the introduction of a new type of adjuvant. However, the complexity and novelty of these
products presents scientific and regulatory challenges, as criteria for their safety, potency and
quality assessment may not always exist. Another important challenge being debated is of the
production of halal vaccine that can be used by Muslims all over the world, which must come
from allowable or permitted sources. The guiding principle of Good Manufacturing Practice
(GMP) is that quality is built into a product, and not just tested. Therefore, the assurance is that the
product not only meets the final specifications, but that it has been made by the same procedures
under the same conditions each and every time it is made. Islamic validation is the part of GMP
that ensures the facility systems, equipments processes and test procedures are in control and
therefore consistently produce a quality vaccine product. Therefore in this paper the halal of
biological manufacturing will be highlighted by discussing the good manufacturing processes and
validation regulations of the vaccine
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1. INTRODUCTION
The concept of vaccination is to stimulate or induce the body's defense system to recognize and
keep into memory the foreign particle that is being introduced into it so that at any point in time it
encounters that foreign particle, It can destroy it without causing any harm to the organism's body,
thus being protected against the deleterious effects of that particle. Islam does not intend to put
forth a new method of manufacturing vaccines rather; it tries to sanitize the processes involved
(from materials used in the process, environment developed for the process, personnel involved in
the process, propagation of the antigenic particle, harvesting, purification, up scaling, storage,
labeling, packaging) so that the whole of humanity can live freely without being selective of what
they have to use, thus, relief of doubts. The Islamic Empire for more than 1000 years remained the
most advanced and civilized nation in the world: This is because Islam stressed the importance and
respect learning, forbade destruction, developed in Muslims the respect for authority and
discipline (Haddad, 1942), and tolerance for other religions (Minkin, 1968). The Muslims
recognized excellence and hungering intellectually were avid for the wisdom of the world of
Galen, Hippocrates, Rufus of Ephesus, Oribasius, Discorides and Paul of Aegina. By the tenth
century their zeal and enthusiasm for learning resulted in all essential Greek medical writings
being translated into Arabic in Damascus, Cairo, and Baghdad. The Muslims became scientific
innovators with originality and productivity. Islamic medicine is one of the most famous and best
known facets of Islamic civilization, and in which the Muslims most excelled. The Muslims were
the great torchbearers of international scientific research (Syed, 2008).
The most brilliant contribution was made by Al-Razi who differentiated between smallpox and
measles, two diseases that were hitherto thought to be one single disease. He is credited with many
contributions, which include being the first to describe true distillation, glass retorts and luting,
147
Ethics of Engineering Education
corrosive sublimate, arsenic, copper sulfate, iron sulphate, saltpeter, and borax in the treatment of
disease. He introduced mercury compounds as purgatives (after testing them on monkeys);
mercurial ointments and lead ointment." Pharmacology took roots in Islam during the 9" century.
Yuhanna bin Masawayh (777-857 A.D.) started scientific and systematic applications of
therapeutics at the Abbasids capital. His students Hunayn bin Ishaq al-Ibadi (809-874 A.D.) and
his associates established solid foundations of Arabic medicine and therapeutics in the ninth
century. In his book al-Masail Hunayn outlined methods for confirming the pharmacological
effectiveness of drugs by experimenting with them on humans. He also explained the importance
of prognosis and diagnosis of diseases for better and more effective treatment. Methods of
extracting and preparing medicines were brought to a high art, and their techniques of distillation,
crystallization, solution, sublimation, reduction and calcinations became the essential processes of
pharmacy and chemistry. With the help of these techniques, the Saydalanis (pharmacists)
introduced new drugs such as camphor, senna, sandal wood, rhubarb, musk, myrrh, cassia,
tamarind, nutmeg, alum, aloes, cloves, coconut, nuxvomic~ cubebs, aconite, ambergris and
mercury (Syed, 2008).
2. ISLAMIC VIEWS ON THERAPEUTICS
Islam is a way of life to live, a system to be followed, a code of ethics and a constitution to be
applied in the daily life of every person. As such, Islam has many constructive ideas to offer in the
fields of health and medicine. In order to find out what Islam teaches, one has to read the Qur'an
and the Hadith. Allah says in the Qur'an (Ash-Shu'ara') about healing from diseases:
"..... and when I sicken, then He (Allah) heals me (QS 26:80)."
As far as the Prophet is concerned, related to the healing of diseases, it was reported by Jabir bin
Abdullah that Prophet Muhammad (pbuh) said:
"For any disease there is a cure, and when the cure matches the disease, the person recovers by the
will of Allah ....."
The prophet also said about the healing of diseases:
It was reported by Abu Hurairah that the Prophet (pbuh) said:
"Allah never inflicts a disease unless he makes a cure for it.... "
As far as the treatment ofdiseases, it was reported by Usamah bin Shareek saying:
"I was with the Prophet (pbuh) and Arabs came to him asking: '0 messenger of Allah: Do we take
medicine for treatment?' He said: 'Yes, Oh you the servants of Allah, take medicine, as Allah
almighty has not created a disease without having created a cure for it except one disease.' They
asked, 'What it is?' He said: 'Old age.''' In another saying: "Allah never inflicts a disease without
providing a cure; only those who were aware of it knew it, whereas those who were not aware
were ignorant of it."
As far as the preventive approach in health, Prophet Muhammad (pbuh) said:
"An ounce of prevention is better than a ton of treatment. II
Hence, healing medicine is an art and a science. It is done through prevention (prophylaxis),
diagnosis, treatment, and cure. In so doing, the individual may prolong his happy life and reduce
the degree and the rate of occurrence of illness. Islam encompasses all these approaches so that a
person may stay healthy, happy and strong.
SeekiAg remedy in Islamic jurisprudence maybe obligatory, encouraged, facultative, makruh or
forbidden (Albar, 2007). It is obligatory in life saving situations; it is haram if it contains amulets,
sorcery, medication made of any intoxicant, using of porcine material, dead carcass even if it is
halal (Quran 2: 168,5:4,5:93 and 2:2(9).
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3. GOOD MANUFACTURING PROCESS (GMP) OF VACCINE
World Health Organization (WHO) defined GMP as part of quality assurance which ensures that
prodUCts are consistently produced and controlled to the quality standards appropriate to their
intended use and as required by the marketing authorization. GMP covers all aspects of
manufacturing steps, suitable premises, storage and transport, qualified and trained production and
quality control personnel, adequate laboratory facilities, approved written procedures and
instructions, records to show all steps of defined procedures have been taken, full traceability of a
product througb batch records and distribution records and systems for recall and investigation of
complaints (Bennet and Cole, 2003). The guiding principle of GMP is that quality is built into a
product, and not just tested. Therefore, the assurance is that the product not only meets the fmal
specifications, but that it has been made by the sarne procedures under the same conditions each
and every time it is made. Validation is the part of GMP that ensures that facility systems,
equipment, processes, and test procedures are in control and therefore consistently produce quality
product (PDA, 2007). Manufacturing viral vaccine today is a complicated process even after the
difficult task of creating a potential vaccine in the laboratory. The effort to manufacture a small
quantity potential vaccine in the laboratory to large production scale is way too complex, and
simple laboratory procedures will not suffice. The development of a vaccine, its characterization,
testing and validation is a great task looking at the candidate that is to be used in the vaccine
development. Non-clinical assessment plays an essential part in the overall development of
vaccine candidates. Currently, there is limited guidance on non-clinical assessment programs for
these products. In the guidance document, the general principles of non-clinical assessment of
vaccines are discussed, with particular attention being given to the regulatory expectations for new
and novel diseases. Non-clinical studies are aimed to define in vitro and in vivo characteristics of
candidate vaccines including safety and immunogenic evaluations. Non-clinical studies in animals
are valuable tools to identify possible risks to the vaccines and help to plan for protocols for
subsequent clinical studies in human subjects. Preclinical testing is a perquisite to move a
candidate vaccine from laboratory to clinic which includes all aspects of testing, product
characterization, proof of immunogenic studies and safety testing in animals conducted before
introducing it into humans. Some of the important elements for the design and the interpretation of
nonclinical testing of vaccines include the biological nature of the starting materials, the
manufacturing process and the test methods required to characterize the batches of the products. In
Muslim country, another important criterion' is to determine the sources of the vaccine itself
whether it comes from allowable sources or not. Many vaccines are produced using prokaryotic
and eukaryotic microorganisms and sligbt changes in these organisms may radically affect the
vaccine product. Moreover, the quality, safety and potency of these products usually are sensitive
to changes in manufacturing conditions. The quality and safety of vaccine preparations cannot be
assured solely by end product testing, but depends on the strict control of the manufacturing
process following principles ofGMP. This includes demonstration of the purity and quality of the
starting material in process control testing, testing for process additives, and process intermediates
and the development and establishment of lot release tests. The development of appropriate
laboratory methods to characterize a vaccine formulation with respect to its components, as well
as its safety and potency, is a perquisite to the clinical use of any new or novel bacterial, viral, or
parasite vaccines. At a minimum, candidate vaccines for clinical trials should be prepared under
conditions of GMP for clinical trial material. However, full GMP will be required at the later
stages of the clinical development. Any change in the manufacturing process during the vaccine
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development should be considered carefully to evaluate the impact on the quality, safety, and
efficacy of the vaccine and the possible need for additional nonclinical and clinical investigations.
As for the production methods, subsequent change in or scale- up following product licensure will
necessitate further product characterization to demonstrate comparability with the original lot used
to demonstrate safety and efficacy of the product. Potency tests measure biological activity of a
vaccine but do not necessarily reflects the mechanism of protection in humans. Potency
measurement is often used to verify the consistency of the manufacturing process. The initial
concept of potency testing for vaccines was to quantify the biological activity of the vaccine in
comparison with reference preparation of known activity, where the antigenic components were
not well defined.
The stability evaluation of vaccines is complex, as they are very susceptible to inactivation by
environmental factors. Potency as defined in the glossary should be measured as a part of the
stability testing, except in those cases where potency testing based on biological activity is not
available. Physical and chemical product characterization should be included in the stability
evaluation. For a product entering human clinical trials, sufficient data should be generated to
support the stability of the product for the duration of the preclinical and clinical trial. In certain
cases, accelerated stability data may be used to support preliminary data generated at the normal
storage temperature. Stability data to support licensure should be carried out under the proposed
storage conditions and should be based on long term real time stability studies. Finally, the
stability of standards and reference materials also need to be considered in order to ensure that
procedures used to measure relevant parameters are reliably standardized.
4. VALIDAnON OF HALAL VACCINES
Developing and licensing a vaccine is a multi faceted process that takes many years. This is
because vaccines are generally given to healthy people, the standards required for ensuring safety
are very high. Validation is defined as the establishing of documented evidence which provides a
high degree of assurance that a planned process will consistently perform according to the
intended specified outcomes including halaL Validation studies are performed for analytical tests,
equipment, facility system such as water, steam, air and for processes such as the manufacturing
processes, cleaning sterilization, sterile filling and lyophilization. Every step of the process to
manufacture a drug product must be shown to perform as intended.
The main pUI'pose of the validation of vaccine and other biopharmaceutical product are to follow
the government regulation, to ensure the high quality of the product produced and to reduce the
cost of production. The GMP and validation concepts are necessary to ensure quality. Regularly,
the validation of a process will lead to quality improvement as well as better consistency. It may
also reduce the dependence upon intensive in-process and finished product testing. The WHO
developed recommendations and guidelines on the production and control of vaccines and other
biological, and these form the basis for ensuring the acceptability of products globally. These
documents specify the need for appropriate starting material including seed lot system and cell
banks; strict adherence to established protocols; test of purity, potency and safety at specific steps
during production; and the keeping of proper records. Upon validation of the vaccines, and the
confirmation of the sources, the halal logo should be displayed on the casting of the product to
ensure that it can be used by the Muslims without ambiguities. This is also to avoid any arising
issues of non-halaI vaccine mistakenly used by the Muslim communities.
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